Menu

LENZ Therapeutics, Inc. LENZ

Full chart Compare
Set alert

Price alert · LENZ

All alert types
3.50 USD +0.49 (+16.28%)

At closeNov 6, 2026, 4:20 PM EST

3.50 0.00 0.00%

After hours · Nov 6, 4:20 PM ET

3.00 Day range 3.51
3.01 52-week range 31.94
YTD
-78.13%
1 year
-84.76%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 54.25 +1450.0% upside
Target (low)
36.00
Target (mean)
54.25
Target (high)
67.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LENZ analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.68908-0.9445 – -0.43-0.38-81.3%4.64M0.0%6
Next quarter-0.80058-0.96 – -0.63346-0.46-74.0%4.16M0.0%6
Current year-2.56-2.75 – -2.15-2.34-9.4%13.81M0.0%7
Next year-2.50-3.65 – -1.75-2.56+2.4%49.12M+255.8%7

Upgrades and downgrades

The latest rating changes

LENZ analyst upgrades and downgrades
DateFirmActionFromTo
Oct 20, 2025Raymond JamesReiteratedOutperformOutperform
Oct 10, 2025Piper SandlerMaintainedOverweightOverweight
Aug 1, 2025CitigroupMaintainedBuyBuy
Aug 1, 2025HC Wainwright & Co.MaintainedBuyBuy
Jul 31, 2025CitigroupMaintainedBuyBuy
Jul 31, 2025Raymond JamesMaintainedOutperformOutperform
Jul 28, 2025HC Wainwright & Co.MaintainedBuyBuy
May 8, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 16, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 14, 2025Piper SandlerMaintainedOverweightOverweight
Mar 20, 2025CitigroupMaintainedBuyBuy
Nov 7, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 27, 2024Raymond JamesInitiated—Outperform
Aug 15, 2024Piper SandlerMaintainedOverweightOverweight
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2024HC Wainwright & Co.Initiated—Buy
Apr 15, 2024Leerink PartnersInitiated—Outperform
Apr 15, 2024William BlairInitiated—Outperform
Apr 10, 2024CitigroupInitiated—Buy
Mar 27, 2024Piper SandlerInitiated—Overweight